Factor Therapeutics Ltd (FTT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Factor Therapeutics Ltd (FTT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6399
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Factor Therapeutics Ltd (FTL), formerly Tissue Therapies Ltd, is a developer of wound care therapeutics. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. Its lead therapeutic candidate, VF-001 is a targeted growth factor which is being developed to treat venous leg ulcers. FTL offers cell culture reagents to enhance the growth of mammalian cells for cell-based therapies. The company’s VF-001 pursues the development of other product candidates which may be applicability to other wound care applications. It utilizes third parties for development and commercialization of its novel products. FTL is headquartered in Brisbane, Queensland, Australia.

Factor Therapeutics Ltd (FTT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Factor Therapeutics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Factor Therapeutics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Factor Therapeutics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Factor Therapeutics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Factor Therapeutics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Factor Therapeutics Ltd, Medical Equipment, Deal Details 10
Equity Offering 10
Factor Therapeutics Raises USD3.3 Million in Rights Offering of Shares 10
Tissue Therapies Completes Rights Offering Of Shares For US$4.5 Million 11
Tissue Therapies Announces Private Placement Of Shares For US$0.5 Million 13
Tissue Therapies Completes Private Placement Of Shares For US$3 Million 14
Tissue Therapies Announces Private Placement Of Shares For US$1.2 Million 16
Factor Therapeutics Ltd – Key Competitors 17
Factor Therapeutics Ltd – Key Employees 18
Factor Therapeutics Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Other Significant Developments 20
Jul 27, 2018: Factor Therapeutics: Appendix 4c – June 2018 quarter 20
Apr 26, 2018: Factor Therapeutics: Appendix 4C – March 2018 Quarter 21
Oct 30, 2017: Factor Therapeutics: Appendix 4C – September 2017 Quarter 22
Jul 31, 2017: Factor Therapeutics: Appendix 4C – June 2017 Quarter 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Factor Therapeutics Ltd, Medical Equipment, Key Facts, 2017 2
Factor Therapeutics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Factor Therapeutics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Factor Therapeutics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Factor Therapeutics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Factor Therapeutics Ltd, Deals By Market, 2012 to YTD 2018 8
Factor Therapeutics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Factor Therapeutics Raises USD3.3 Million in Rights Offering of Shares 10
Tissue Therapies Completes Rights Offering Of Shares For US$4.5 Million 11
Tissue Therapies Announces Private Placement Of Shares For US$0.5 Million 13
Tissue Therapies Completes Private Placement Of Shares For US$3 Million 14
Tissue Therapies Announces Private Placement Of Shares For US$1.2 Million 16
Factor Therapeutics Ltd, Key Competitors 17
Factor Therapeutics Ltd, Key Employees 18
Factor Therapeutics Ltd, Other Locations 19
Factor Therapeutics Ltd, Subsidiaries 19

List of Figures
Factor Therapeutics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Factor Therapeutics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Factor Therapeutics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Factor Therapeutics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Factor Therapeutics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Factor Therapeutics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Factor Therapeutics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Factor Therapeutics Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Factor Therapeutics Ltd (FTT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Robinson Helicopter Company, Inc.:企業の戦略・SWOT・財務分析
    Robinson Helicopter Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Robinson Helicopter Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Flight Centre Travel Group Limited (FLT):企業の財務・戦略的SWOT分析
    Flight Centre Travel Group Limited (FLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Greif Inc (GEF):企業の財務・戦略的SWOT分析
    Greif Inc (GEF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Epax Norway AS:戦略・SWOT・企業財務分析
    Epax Norway AS - Strategy, SWOT and Corporate Finance Report Summary Epax Norway AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Mayne Pharma Group Ltd (MYX)-製薬・医療分野:企業M&A・提携分析
    Summary Mayne Pharma Group Ltd (Mayne Pharma), formerly Mayne Pharma International Pty Ltd, a subsidiary of Hospira Inc, is a specialty pharmaceutical company that manufactures and markets branded and generic medicinal products. The company’s products comprise astrix capsules and tablets, erymax cap …
  • PT Bank Central Asia Tbk:企業の戦略・SWOT・財務情報
    PT Bank Central Asia Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Bank Central Asia Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Genus Power Infrastructures Ltd (GENUSPOWER):企業の財務・戦略的SWOT分析
    Summary Genus Power Infrastructures Ltd (Genus Power), a subsidiary of Kailash Group, is an electronic equipment manufacturer that develops and distributes electric energy equipment. The company’s products include metering solution products, engineering construction and contracts, solar energy solut …
  • Posco International Corp (047050):企業の財務・戦略的SWOT分析
    Posco International Corp (047050) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Bawag Psk
    Bawag Psk - Strategy, SWOT and Corporate Finance Report Summary Bawag Psk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • DBS Bank Ltd:企業のM&A・事業提携・投資動向
    DBS Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DBS Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Mediware Information Systems Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Mediware Information Systems Inc (Mediware), a subsidiary of TPG Capital is a healthcare solutions company that designs, develops and commercializes specialized healthcare software. It provides software to healthcare and human service providers and payers. The company’s portfolio of solution …
  • Chromalloy Gas Turbine LLC:企業の戦略・SWOT・財務情報
    Chromalloy Gas Turbine LLC - Strategy, SWOT and Corporate Finance Report Summary Chromalloy Gas Turbine LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • ERG SpA (ERG):電力:M&Aディール及び事業提携情報
    Summary ERG S.p.A. (ERG), a subsidiary of San Quirico S.P.A., is a diversified energy company. Through its subsidiaries, it conducts power generation through renewable and thermal sources. The company carries out the distribution and marketing of petroleum products and conducts refining activities. …
  • Bio-Rad Laboratories, Inc.:企業の戦略・SWOT・財務分析
    Bio-Rad Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bio-Rad Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • The Boston Beer Company, Inc.:企業の戦略・SWOT・財務分析
    The Boston Beer Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Boston Beer Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • OMV Petrom SA (SNP):企業の財務・戦略的SWOT分析
    OMV Petrom SA (SNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • NanoString Technologies Inc (NSTG):医療機器:M&Aディール及び事業提携情報
    Summary NanoString Technologies Inc (NanoString) is a developer of life science tools for translational research and molecular diagnostics. The company's products include sprint profiler, Dx analysis system with flex, nCounter MAX analysis system, protein assays, solid tumor assays, gene fusion pane …
  • Euskaltel, S.A. (EKT):企業の財務・戦略的SWOT分析
    Euskaltel, S.A. (EKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Huntington Memorial Hospital:企業の戦略的SWOT分析
    Huntington Memorial Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • SJVN Ltd (SJVN)-エネルギー分野:企業M&A・提携分析
    Summary SJVN Limited (SJVN), formerly Satluj Jal Vidyut Nigam Limited-SJVNL, generates and sells hydroelectric power in India. It was formed as a joint venture between the Government of India (GOI) and the Government of Himachal Pradesh (GOHP). The company also focuses on the designing, planning, de …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆